AI-generated human imagery is reshaping pharmaceutical marketing, offering new opportunities for scale and efficiency while raising the stakes for authenticity, governance, and patient trust. The challenge is no longer whether to use AI, but how to apply it responsibly.
Market access is no longer a final step—it’s becoming a foundational strategy. Insights from Asembia’s AXS26 Summit highlight a clear shift toward earlier integration, clearer data storytelling, and deeper collaboration across payers, manufacturers, and partners to navigate an increasingly complex healthcare landscape.
Explore key takeaways from the ISMPP Annual Meeting, including AI in medical publications, journal targeting strategies, and evolving industry challenges.
A perspective from Adobe Summit 2026 on how AI is reshaping healthcare marketing—not by replacing agencies, but by eliminating outdated, inefficient processes. While fears around job loss and shrinking budgets are real, the true shift is toward scalable, personalized engagement that improves patient outcomes. Human creativity and strategy remain essential, with AI acting as the engine that enables more meaningful, timely connections at scale.
Clear communication keeps clinical trials moving by improving recruitment, engagement and retention across sites and participants. As trial pressures grow, effective communication is increasingly what separates successful studies from those that stall.
